Who discovered thymosin beta-4?

Low and colleagues published the complete bovine sequence in PNAS in February 1981.

Was TB-500 part of the 1981 work?

No. The fragment came later, once actin binding had been localised to the LKKTETQ motif.

The Discovery of Thymosin Beta-4 in 1981

The short answer

Low and colleagues published the complete amino acid sequence of bovine thymosin beta-4 in the Proceedings of the National Academy of Sciences in February 1981, describing it as a thymic hormone. Its principal role as a G-actin sequestering protein was recognised later.

Key facts

Publication: PNAS, February 1981 (PMID 6940133)
First author: Low TL
Source: Bovine thymus
Length: 43 residues
Original description: Thymic hormone
Later understanding: G-actin sequestering protein

Where the name comes from

Thymosin refers to the thymus, the tissue the protein was isolated from. It was one of several thymic factors investigated in that era, when the thymus was a major focus of immunological research and preparations from it were expected to contain immune-regulating hormones.

What the 1981 paper reported

The complete amino acid sequence of the bovine protein: 43 residues, fully determined. Establishing a complete sequence in 1981 was substantial work, and it is what makes the paper a foundational reference rather than a preliminary report.

Research material referenced

TB-500 5mg, third-party HPLC tested

Buy TB-500 · £23.99

The framing that did not survive

It was described as a thymic hormone. That characterisation has not held: thymosin beta-4 is now understood principally as an intracellular actin-sequestering protein present in many cell types, not as a hormone secreted by the thymus to act elsewhere. This is a normal trajectory for a molecule named before its function was known, and the name outlasted the hypothesis.

Why the reframing matters

A hormone acts at a distance on cells bearing receptors for it. An intracellular actin-binding protein does not. The two imply completely different pharmacology, and the older framing lingers in secondary writing in ways that imply a signalling role the current understanding does not support.

From protein to fragment

TB-500 came much later, once the actin-binding activity had been localised to LKKTETQ and it became practical to synthesise the motif alone. The development code TB-500 belongs to that later phase, not to the 1981 work. That matters, because citing the discovery paper as a TB-500 reference attributes the fragment to research that predates it.

Frequently asked questions

Who discovered thymosin beta-4?: Low and colleagues published the complete bovine sequence in PNAS in February 1981.
Is it really a thymic hormone?: That was the original framing and it has not held. It is now understood principally as an intracellular G-actin sequestering protein found in many cell types.
Was TB-500 part of the 1981 work?: No. The fragment came later, once actin binding had been localised to the LKKTETQ motif.

Extended research context

The TB-500 (Thymosin β4 fragment) deep dive

Deep dive: TB-500 vs full-length Thymosin Beta-4

'TB-500' is a synthetic peptide corresponding to the active 17-amino-acid actin-binding region of the endogenous 43-residue Thymosin Beta-4 protein. The two are not identical. TB-500 lacks the flanking sequence that gives full-length TB-4 additional binding partners. In the research literature, papers use 'Thymosin β4' when they mean the full protein and 'TB-500' or 'AcSDKP fragment' when they mean the shorter synthetic peptide. Reading a CoA carefully to see which molecule is in the vial matters. Mass spec is the definitive check.

Actin-binding as the core mechanism

The N-terminal region of TB-4 (and TB-500 by inheritance) contains the canonical actin-binding motif. This motif sequesters G-actin monomers, modulating the G:F actin equilibrium in cell cultures. That mechanism is why almost every mechanistic paper on TB-500 traces back to cytoskeletal reorganisation, cell migration, and models of tissue repair.

Handling considerations unique to TB-500

TB-500 is a 17-residue peptide with modest amphipathicity; it reconstitutes cleanly in bacteriostatic water but is sensitive to repeated freeze/thaw. Aliquoting into single-use volumes on first reconstitution preserves potency across a batch. HPLC on the batch CoA should show a single dominant peak; a doublet suggests deamidation.

Research applications

▸In vitro actin-polymerisation assays (G:F actin ratio measurement)
▸Cell-migration and wound-scratch assays in fibroblast lines
▸Angiogenesis models: tube-formation and endothelial migration assays
▸Analytical method development for short peptides on RP-HPLC
▸Reference-material comparisons against endogenous Thymosin β4

Handling checklist

✓Store lyophilised vials at −20 °C long-term
✓Reconstitute with bacteriostatic water (0.9% benzyl alcohol)
✓Aliquot immediately to avoid freeze/thaw cycles
✓Refrigerate reconstituted aliquots at 2–8 °C; use within 28 days
✓Confirm mass (~4,963 Da for TB-500) via CoA before study use

Common research-handling mistakes

Learnt from thousands of researcher orders across our UK labs.

✗ Assuming TB-500 = full Thymosin β4

Fix: TB-500 is the 17-residue actin-binding fragment; check the CoA sequence.

✗ Repeated freeze/thaw

Fix: Aliquot at first reconstitution; each cycle degrades yield.

✗ Using tap water

Fix: Use bacteriostatic or sterile water only.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

UKP

Written and reviewed by

The UK Peptides Editorial Team · Research library, UK Peptides

The editorial team is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate. Corrections are made in place and the review date updated.

How we write and check this content Report a factual error in this article

More TB-500 (Thymosin β4 fragment) articles

Popular across the research hub

One flagship guide from every other research category.

← Back to Forum

How Thymosin Beta-4 Was Discovered